GEN Exclusives

More »

GEN News Highlights

Back to Item »

Vertex Plans EU and U.S. Filing for CF Therapy This Year Following Phase III Success

Strive trial showed VX-770 boosts lung function in patients with at least one G551D mutation.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should the CDC Director Resign?

Do you think the CDC chief should resign?